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Porcine plasma and factor VIII preparations were 
screened for parvovirus 4 (PARV)–like viruses. Although the 
prevalence of PARV4-like viruses in plasma samples was 
relatively low, viruses appeared to be concentrated during 
manufacture of factor VIII. PARV4-like viruses from human 
and porcine origins coevolved likewise with their hosts.
I
n 2005, a previously unknown virus, parvovirus 4 
(PARV4), was detected in a plasma sample from a 
hepatitis B–positive injection drug user (IDU) (1). Al-
though PARV4 was subsequently detected in plasma from 
healthy donors, its prevalence is higher in samples from 
IDUs, AIDS patients, and hepatitis C virus–infected per-
sons (2,3). In recent serologic studies, 67% of HIV-infected 
IDUs had antibodies to PARV4, whereas non-IDU controls 
were seronegative (4) This increased prevalence in IDUs 
and persons with hemophilia most likely reﬂ  ects parenteral 
transmission of the virus (4,5). Furthermore, PARV4 was 
frequently detected in human coagulation factor concen-
trates prepared from older plasma samples (6). The lower 
detection frequency in current concentrates may be due to 
exclusion of high-risk batches, e.g., from IDU or hepatitis 
C virus–infected persons during plasma collection, and to 
improved puriﬁ  cation methods. The presence of PARV4 
in plasma suggests a viremic phase enabling spread of the 
virus to different organs. Even though recent studies by 
Kleinman et al. indicate that parvovirus B19 is not readily 
transmitted to susceptible hosts by blood component trans-
fusion, similar evaluation of PARV4 transmission will be 
invaluable in assessing the need to routinely screen for this 
emerging virus (7).
PARV4 contains a 5-kb single-stranded DNA genome 
with inverted terminal repeats and a large open read-
ing frame (ORF) in each half of the genome coding for 
nonstructural (NS) protein and structural protein, re-
spectively. PARV4-like viruses form a separate cluster 
among the parvoviruses (1,8). Three genotypes of human 
PARV4 parvoviruses with ≈93% nucleotide sequence 
identity have been described. The sequence of genotype 
1 (PARV4-g1) is highly conserved, whereas that of geno-
type 2 (PARV4-g2 [formerly PARV5]) is somewhat more 
diverse. PARV4-g2 is found mostly in older coagulation 
factor concentrates (1960s–1980s), suggesting that geno-
type 1 emerged recently (6,8). A third genotype (PARV4-
g3) was isolated from persons in sub-Saharan Africa 
(9). Additionally, PARV4-like viruses with a 60%–65% 
nucleotide identity were recently identiﬁ  ed at high fre-
quencies in porcine and bovine tissue samples in People’s 
Republic of China (10).
In this study, porcine plasma samples and factor VIII 
(FVIII) concentrates used by persons with hemophilia who 
have autoimmune antibodies against human FVIII were in-
vestigated for PARV4-like viruses. We then determined the 
degree of identity of these isolates with the human virus.
The Study
Plasma samples from healthy pigs were collected 
in Great Britain in 2001. Initially, these samples were 
tested for PARV4-like viruses by using previously de-
scribed degenerate PCR primers (10). DNA was extract-
ed from samples by using the High Pure DNA Isolation 
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Figure 1. Parallel PCR ampliﬁ  cation of PARV4-like (A) and PPV 
(B) by using puriﬁ   ed DNA from clotting FVIII preparations. The 
results of this PCR usually suggested a higher PARV4 load despite 
the higher efﬁ   ciency of the PPV PCR (J. Szelei and P. Tijssen, 
unpub. data). This ﬁ   nding was conﬁ   rmed with the quantitative 
MIMIC PCR method for PPV (11). Numbers indicate different lots 
of FVIII prepared in 1:1994A, 2:1994B, 3:1996A, 4:1996B, 5:1999, 
6:2000A, 7:2000B, 8:2001A, 9:2001B, 10:2001C, 11:2001D, and 
12: DNA marker (1-kb ladder; Invitrogen, Carlsbad, CA USA). 
PARV4, parvovirus 4; PPV, porcine parvovirus; FVIII, factor VIII.Kit (Roche Applied Science, Roche Diagnostics Can-
ada; Laval, Quebec, Canada). Only 3 of the 98 plasma 
samples contained detectable amounts of PARV4-like 
viruses. To further study these porcine viruses, we ob-
tained nearly full-length genomes from overlapping PCR 
fragments. Primers designed for these PCRs were PrS1: 
5′-CCACACCTACCTCGCCTATAAGAATCAG-3′; 
PrAS1: 5′-CTCCACTTGTTCAGCACGGGATCC-3′; 
PrS2: 5′-CCACGAGCTGGAAGTCTTTA-3′; PrAS2: 5′-
GGAGTCCGCATACCCATAACAGGCTG-3′; PrS3: 5′-
GTGTACCGCAGTGGGAGCCATG-3′; and PrAS3: 5′-
TTCTGGGCAACCCACTGATCAGAAGG-3′. The nearly 
full-length clones were sequenced by primer-walking. Ge-
nomic analysis conﬁ  rmed that these viruses were related to 
the PARV4 viruses and were close relatives of the recently 
identiﬁ  ed porcine hokoviruses (PHoVs) (10).
We also conﬁ  rmed the moderate frequency of PARV4-
like viremia in the previously tested pig plasma samples 
with a more sensitive PCR assay by using speciﬁ  c primers 
PrS4 (5′-AGTTACGGGGGACCGCTACAGTG-3′) and 
PrAS3. In contrast, examination of 11 commercial clotting 
FVIII preparations showed that all of these independent 
lots contained substantial amounts of PARV4-like parvo-
virus, whereas the level of porcine parvovirus DNA was 
generally lower in the corresponding samples (Figure 1). 
Similar to the plasma samples, long overlapping PCR frag-
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Table 1. Percentage diversity of genome sequences of PARV4-like viruses*† 
Genotype PARV4-p PHoV BHoV PARV4-g1 PARV4-g2
PARV4-p 98–99
PHoV 97–98 98–99
BHoV 62 62 99
PARV4-g1 58 58 60 98–100
PARV4-g2 58–59 58 59–60 91–92 96–99
PARV4-g3 58 58 60 92 91–92
*PARV4, parvovirus type 4; PARV4-p, porcine PARV-4; PHoV, porcine hokovirus; BHoV, bovine hokovirus; PARV4-g1, PARV4 genotype 1; PARV4-g2, 
PARV4 genotype 2; PARV4-g3, PARV4 genotype 3.  
†Pairwise sequence comparisons were performed by using the ClustalW program (www.ebi.ac.uk/Tools/clustalw) as described in Figure 2 and 
percentages of sequence identities were calculated. Nucleotide sequences representing the equivalent regions (position 248–5088, numbered according 
to the PARV4 sequence NC_007018) were used to align the DNA fragments.  
Table 2. Analysis of relationships among the protein sequences of PARV4-like viruses*† 
Sequence PARV4-p PHoV BHoV PARV4-g1  PARV4-g2  PARV4-g3 
PARV4-p 
NS 99–100  (99) (80) (68) (68) (68) 
VP 99–100  (99) (79) (77) (78) (77) 
SAT 100
PHoV
NS 97–98 98–99  (79)  (68)  (68)  (68)
VP 99 99 (79) (77) (77) (77) 
SAT 98–100 98–100 
BHoV
 NS  67–68  67 99 (70)  (70)  (70) 
 VP  66 66 NA (78)  (78)  (78) 
 SAT  79 79 100
PARV4-g1 
 NS  53–55  53–54  56–57  96–99  (99)  (98) 
VP 65 65 65 99 (99) (98–99) 
 SAT  59 59 59 100
PARV4-g2 
 NS  54–55 53–54  56 96–97  98–99  (98) 
VP 65 65 64–65 98 98–99  (98) 
 SAT  59 59 59 100 100
PARV4-g3 
NS 54 53–54 56 96–97  96–97 NA
VP 65 65 64 98 97–98 NA
 SAT  59 59 59 100 100
*PARV4, parvovirus type 4; PARV4-p, porcine PARV-4; PHoV, porcine hokovirus; BHoV, bovine hokovirus; PARV4-g1, PARV4 genotype 1; PARV4-g2, 
PARV4 genotype 2; PARV4-g3, PARV4 genotype 3; NS, nonstructural protein; VP, viral protein; NA, no alignment; SAT, small alternatively translated 
proteins. 
†Numbers indicate percentages of amino acid sequence identity; numbers in parentheses indicate percentages of amino acid similarity (preserved 
physicochemical properties). Sequence similarity was not calculated for the SAT proteins, because of their relatively smaller size. When only 1 sequence 
was available (e.g., VP of BHoV), no alignment was performed.  PARV4-like Virus in Blood Products
ments were ampliﬁ  ed from the FVIII preparations to obtain 
nearly full-length sequences. Their analysis provided infor-
mation about the evolution of PARV4-like viruses, during 
nearly a decade, in pigs. Sequence data were registered by 
GenBank (accession nos. Cl2001A: FJ982246; Cl2001B: 
FJ982247; Cl2001C: FJ982248; F8–1994A: FJ982249; 
F8–1994B: FJ982250; F8–1996A: FJ982251; F8–1996B: 
FJ982252; F8–1999: FJ982253; F8–2000A: FJ982254; and 
F8–2000B: FJ982255). Phylogenetic and molecular evolu-
tionary analyses were conducted by using MEGA version 
4 (12).
The genomes of these newly isolated PARV4-like 
viruses were similar to the PHoVs previously identiﬁ  ed 
in Hong Kong Special Administrative Region, People’s 
Republic of China. Although, these new isolates showed 
some diversity (98%–99% identity), they differed some-
what more from the PHoVs (97%–98% identity). The viral 
protein (VP)-ORF was highly conserved (99%), whereas 
the NS-ORF showed more diversity (97%–98%). Genomic 
and protein-coding sequences were also compared with 
other PARV4-like viruses (Tables 1, 2). Phylogenic analy-
sis using neighbor-joining and maximum parsimony meth-
ods demonstrated that PHoVs grouped together, whereas 
PARV4-like sequences from FVIII prepared at different 
times were less uniform (Figure 2). Older FVIII PARV4 
contaminants (especially from 1994) were related more 
closely to the bovine hokoviruses (BHoVs) and to PARV4-
g2. Finally, analysis of the newly identiﬁ  ed virus genomes 
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Figure 2. Construction of phylogenic trees for newly identiﬁ  ed porcine viruses and comparison with previously identiﬁ  ed prototype parvovirus 
4 (PARV4)–like sequences. Sequences of other PARV4-like viruses indicated by the accession numbers were obtained from GenBank, 
and their origins are marked by letters (p, porcine; b, bovine; PARV4-g1, g2, g3, human parvovirus 4 genotypes 1, 2, and 3). ClustalW-
aligned genomes (A) and nonstructural (NS) protein (B) and viral protein (VP) (C) were all trimmed to obtain sequences with similar 
lengths. All computer analysis was performed by using the neighbor-joining method. Branches corresponding to partitions reproduced 
in <70% bootstrap replicates are collapsed. The tree is drawn to scale, and the percentage of replicate trees in which the associated 
taxa clustered together in the bootstrap test (1,000 replicates) are shown below the branches. F8-year, year of the factor VIII lot; Cl-year, 
plasma samples and year of collection. Scale bar represents the number of nucleotide (A) or amino acid (B, C) substitutions per site.showed an alternative coding sequence inside of the VP 
gene with a recognizable relationship to small alternatively 
translated proteins (SAT) (13). In the porcine PARV4-like 
viruses, the start codon for the SAT protein was 3 nt down-
stream relative to the position of SAT-ATG in the human 
and bovine PARV4 viruses. Although the SAT protein was 
67 aa in all the characterized human PARV4 viruses, por-
cine and bovine PARV-like viruses contained SAT proteins 
with 84 aa. The amino acid sequences of the SAT proteins 
were highly conserved in each PARV4 virus group; how-
ever, they differed greatly between PARV4 viruses belong-
ing to different host species (Table 2).
Conclusions
Improved virus detection methods have facilitated the 
discovery of new viruses and have provided insight into the 
existence of a wide variety of potentially pathogenic strains 
in biopharmaceutical products. Plasma samples, collected 
from individual pigs in 2001–2002, and FVIII samples, 
prepared during 1994–2001, were tested for PARV4-like 
viruses.
Sequence analysis showed that PARV4-like viruses 
may have undergone some degree of selective pressure 
during this time because the genomes sequenced showed a 
greater variability than the porcine parvovirus NS sequenc-
es isolated from the same samples (J. Szelei and P. Tijs-
sen, unpub. data). In the current study, comparison of the 
genomic and NS protein coding sequences indicated that 
viruses in the older samples were more closely related to 
BHoV and PARV4-g2 (Figure 2). Fewer changes were ob-
served in the VP coding sequence (Table 2). Because VPs 
are responsible for the entry of parvoviruses, they usually 
adapt to host-speciﬁ  c receptor(s). The presence of PARV4-
g2–like isolates in older samples and the omnipresence of 
PARV4-like viruses in more recent samples suggested that 
the porcine PARV4-like virus and human PARV4 may 
have similarly evolved (8). These new parvovirus isolates 
from Great Britain would belong to a different cluster of 
porcine PARV4-like viruses than the hokoviruses from 
Hong Kong Special Administrative Region.
Although older isolates shared more identity with 
BHoV and PARV4-g2, the substantial differences in the 
DNA sequences of PARV4-like viruses from different spe-
cies (human, bovine, pig) suggested that they would have 
diverged a long time ago. This hypothesis was also sup-
ported by the sequence stabilization of the SAT proteins, 
which may play important host-speciﬁ  c roles in the viral 
exit (13). Nevertheless, the existence of a wide variety of 
different PARV4 strains, most of which result in chronic 
infections, could provide a basis for an evolutionary jump 
and recombination and should raise major concerns about 
the dangers of parenteral transmission.
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